Ketoford Eye Drop contains Ketorolac 0.5% w/v, a nonsteroidal anti-inflammatory drug (NSAID) indicated for the relief of ocular inflammation and pain associated with seasonal allergic conjunctivitis, postoperative inflammation following cataract surgery, and other inflammatory conditions of the eye. Ketorolac exerts its therapeutic effect by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the synthesis of prostaglandins, which are mediators of inflammation and pain. This topical formulation allows for targeted delivery, minimizing systemic exposure and associated adverse effects. Ketoford Eye Drop is typically administered as one drop in the affected eye(s) four times daily or as directed by a healthcare professional. It is contraindicated in patients with hypersensitivity to ketorolac or any component of the formulation, and caution is advised in individuals with bleeding disorders or those using other NSAIDs. Common side effects may include transient burning or stinging upon instillation, ocular irritation, and headache. Patients should avoid contact lens use during treatment unless otherwise advised. Ketoford Eye Drop should be used under medical supervision, with adherence to prescribed dosing to optimize therapeutic outcomes while minimizing potential risks.